CD19p for CAR detection

SKU: PCD19-0212-25T Category:

595,00 € – 2.019,00 € VAT excl.

Immunostep’s CD19 CAR T-Cell is an antigen-based reagent consisting of the human CD19 extracellular domain (20-291) conjugated to fluorocrhome using a proprietary technology (BrightStep®) that enhances the detection of CAR T-Cells.

Additional information

Conjugated

Size

,

Regulatory Status

Format

Tested Applications

Mw

Storage Store in the dark at 2-8°C.
Other names

B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, Differentiation antigen CD19, T-cell surface antigen Leu-12, B4; MGC12802.
Buffer

The reagent is provided in aqueous buffered solution containing protein stabilizer, and ≤0.09% sodium Azide (NaN3).
Concentration

Please refer to the Certificate of Analysis for the lot-specific concentration. Typically 0,05 mg/ml.

Recomended usage

Immunostep’s CD19 CAR T reagent has been developed for the detection and quantification of transduced T cells that are engineered to express CD19-specific chimeric antigen receptor (CAR) on the cell surface by direct immunofluorescence flow cytometry protocol.

Resources

Technical Data Sheet (TDS) (RUO) – (English)

Safety Sheet (MSDS) (RUO) – (English)

Whitepaper – CAR T BrightStep (English)

References

Product descriptionReferenceTitleAuthorsJournalYear
Product descriptionReferenceTitleAuthorsJournalYear
logo_footer

Follow us on our networks and stay informed.

LOCATION:

Centro Investigación del Cáncer (C.I.C) Avda. Universidad de Coimbra, s/n Campus Miguel de Unamuno 37007 Salamanca

+34 923 294 827 

info@immunostep.com

NextGenEU
Plan de Recuperación, Transformación y Resiliencia

© 2024 Immunostep